Anika Therapeutics Inc. · NASDAQ:ANIK
Henneman John B III bought 5,000 Anika Therapeutics Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 4, 2026
On May 1, 2026, Henneman John B III (Director) bought 5,000 Anika Therapeutics Inc. shares at US$14.66 for US$73,300, leaving 54,871 shares. Filed May 4, 2026 (Form 4).
- Bought
- 5,000 shares
- Price
- US$14.66
- Value
- US$73,300
- Holding after
- 54,871 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Buy | 5,000 | US$14.66 | 54,871 | Direct |
Source
Related
- Anika Therapeutics Inc.
- Henneman John B III
- Anika Therapeutics Inc. shareholders
- Form 4 · Henneman John B III · Jun 23, 2026
- Form 4 · Fischetti Gary P · Aug 5, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jul 17, 2026
- Form 4 · Fischetti Gary P · Jun 23, 2026
- Form 4 · Richard Stephen · Jun 23, 2026